Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC01796 (Long intergenic non-protein coding RNA 1796) is a long intergenic non-coding RNA gene in the human genome[1]. LincRNAs like LINC01796 are over 200 nucleotides long and do not overlap protein-coding genes. They function as part of a diverse class of non-protein coding RNAs, which are recognized for their roles in fine-tuning the expression of neighboring or distant genes, often displaying tissue-specific expression patterns. Well-characterized lincRNAs regulate chromatin structure, transcription, and aspects of nuclear architecture, but for the vast majority—including LINC01796—specific biological or pathological roles have not yet been well established[5]. No direct link to human disease, drug targeting, or biomarker status is currently assigned to LINC01796 in major genetic or medical databases[1].
Not applicable. No drug mechanisms target this molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1796 (LINC01796).